Genesis Unicorn Capital in an 8-K said it issued a promissory note to its sponsor for up to $4.5 million that would be used as needed to secure deadline extensions up until February 2024.
The SPAC raised $75 million in a February 2022 IPO with plans to focus on the intersection of the healthcare and technology industries, specifically within the biotechnology and pharmaceutical sectors. Read more.
